Abstract
Abstract: This article highlights important prescribing information for some drugs that received FDA approval within the past year. These include: atazanavir and cobicistat (Evotaz(R)), ceftazidime and avibactam (Avycaz(R)), edoxaban (Savaysa(R)), ivabradine (Corlanor(R)), liraglutide (rDNA origin) injection (Saxenda(R)), perindopril arginine and amlodipine besylate (Prestalia(R)), and secukinumab (Cosentyx(R)) subcutaneous injection.